Company Overview

Psyched Wellness Ltd. is a Canada-based life sciences company operating in the nutraceutical, functional food, and wellness industries, with a strategic focus on products derived from the Amanita muscaria mushroom. The company’s primary business involves the development, commercialization, and sale of legal, non-psychedelic mushroom-derived consumer products intended to support relaxation, sleep, and overall wellness. Psyched Wellness does not operate in the controlled psychedelic drug development space; instead, it positions itself within the regulated consumer health and wellness market.

The company’s principal revenue driver is its Amanita muscaria-derived branded product, Calm, which is marketed as a legal wellness supplement in jurisdictions where permitted. Psyched Wellness targets health-conscious consumers, wellness retailers, and direct-to-consumer customers, primarily in North America. Its strategic positioning is based on being one of the first publicly traded companies to commercialize Amanita muscaria products at scale while emphasizing compliance, safety testing, and standardized extraction processes. The company was incorporated in 2020 and evolved from early-stage research and intellectual property development into commercial sales following regulatory reviews and supply chain establishment.

Business Operations

Psyched Wellness operates through a single primary operating segment focused on the research, development, manufacturing, and commercialization of mushroom-based wellness products. Revenue is generated through direct-to-consumer online sales and wholesale distribution of its Calm product, which utilizes a proprietary water-based extraction method designed to remove ibotenic acid while preserving muscimol content. The company maintains control over its formulation, branding, and quality assurance processes, while manufacturing is supported through third-party partners.

Operations are primarily concentrated in North America, with corporate, regulatory, and commercialization activities managed from Canada and the United States. Psyched Wellness holds intellectual property related to its extraction processes and product formulations and relies on third-party laboratories for safety testing and verification. Based on publicly available disclosures, the company does not report material joint ventures, and its operations are conducted through wholly owned subsidiaries.

Strategic Position & Investments

The company’s strategic direction centers on expanding consumer awareness and distribution of Amanita muscaria-based wellness products while maintaining regulatory compliance in key markets. Growth initiatives include broadening retail partnerships, enhancing e-commerce capabilities, and developing additional product formats within the wellness category. Psyched Wellness has stated its intent to pursue further research into functional mushroom applications that remain outside controlled-substance regulatory frameworks.

Psyched Wellness has not disclosed significant acquisitions or large-scale equity investments in unrelated businesses. Instead, capital deployment has focused on internal product development, marketing, supply chain optimization, and regulatory review. The company’s strategy emphasizes first-mover advantage in a niche wellness category, supported by branding, education, and safety-focused differentiation. Public filings do not indicate material investments in emerging psychedelic drug technologies.

Geographic Footprint

Psyched Wellness is headquartered in Canada, with operational and commercial activities spanning Canada and the United States. The company’s primary consumer market is the U.S., where its products are sold online and through select retail channels, subject to state-level regulations. Canadian operations support corporate governance, research oversight, and strategic planning.

The company does not report material operations outside North America, and there is no verified public disclosure of manufacturing facilities or subsidiaries in other continents. International expansion beyond the U.S. and Canada has been referenced as a potential long-term opportunity, but concrete operational presence outside these regions remains limited based on available public sources.

Leadership & Governance

Psyched Wellness is led by executives with experience in capital markets, consumer products, and early-stage life sciences. The leadership team emphasizes regulatory compliance, consumer safety, and disciplined commercialization as core elements of its governance and operating philosophy. The company is governed by a board of directors responsible for strategic oversight, risk management, and alignment with shareholder interests.

Key executives include:

• Jeffrey Stevens – Chief Executive Officer
• Matthew Singh – Chief Financial Officer
• Diana Jenkins – President
• David Shisel – Chief Operating Officer

The leadership team’s stated strategic vision focuses on building a credible, compliant wellness brand in an emerging category while avoiding regulatory risks associated with controlled psychedelic substances.